Sign In

Login

Password

Forgot Password ? Sign Up

臨床評価項目 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "臨床評価項目" in Japanese language version.

refsWebsite
Global rank Japanese rank
7nih.gov
4th place
24th place
6doi.org
2nd place
6th place
4igaku-shoin.co.jp
low place
2,821st place
2cancer.gov
1,684th place
6,245th place
2fda.gov
447th place
1,043rd place
1uu.nl
2,467th place
8,576th place
1web.archive.org
1st place
1st place
1ed.ac.uk
1,871st place
2,715th place
1jcog.jp
low place
low place
1mwsug.org
low place
low place
1pmda.go.jp
6,690th place
394th place

cancer.gov

doi.org

  • Biomarkers Definitions Working Group (March 2001). “Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework”. Clinical Pharmacology & Therapeutics 69 (3): 89–95. doi:10.1067/mcp.2001.113989. PMID 11240971. 
  • De Gruttola, Victor G; Clax, Pamela; DeMets, David L; Downing, Gregory J; Ellenberg, Susan S; Friedman, Lawrence; Gail, Mitchell H; Prentice, Ross et al. (October 2001). “Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials”. Controlled Clinical Trials 22 (5): 485–502. doi:10.1016/S0197-2456(01)00153-2. PMID 11578783. 
  • Cohn, J. N. (29 June 2004). “Introduction to Surrogate Markers”. Circulation 109 (25 suppl 1): IV–20–IV-21. doi:10.1161/01.CIR.0000133441.05780.1d. PMID 15226247. 
  • Handforth, C.; Hall, P.; Marshall, H.; Seymour, M. (October 2013). “Overall treatment utility: A novel outcome measure to convey the balance of benefits and harms from cancer treatment”. Journal of Geriatric Oncology 4: S49. doi:10.1016/j.jgo.2013.09.064. 
  • Core Outcomes in Women's Health (CROWN) Initiative (2014). “The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health”. Journal of Gynecologic Oncology 25 (3): 166–7. doi:10.3802/jgo.2014.25.3.166. PMC 4102731. PMID 25045427. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102731/. 
  • Penninckx, B; Van de Voorde, W M; Casado, A; Reed, N; Moulin, C; Karrasch, M (26 June 2012). “A systemic review of Toxic Death in clinical oncology trials: an Achilles' heel in safety reporting revisited”. British Journal of Cancer 107 (1): 1–6. doi:10.1038/bjc.2012.252. PMC 3389431. PMID 22677904. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389431/. 

ed.ac.uk

blogs.ed.ac.uk

fda.gov

fda.gov

accessdata.fda.gov

igaku-shoin.co.jp

jcog.jp

mwsug.org

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Biomarkers Definitions Working Group (March 2001). “Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework”. Clinical Pharmacology & Therapeutics 69 (3): 89–95. doi:10.1067/mcp.2001.113989. PMID 11240971. 
  • De Gruttola, Victor G; Clax, Pamela; DeMets, David L; Downing, Gregory J; Ellenberg, Susan S; Friedman, Lawrence; Gail, Mitchell H; Prentice, Ross et al. (October 2001). “Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials”. Controlled Clinical Trials 22 (5): 485–502. doi:10.1016/S0197-2456(01)00153-2. PMID 11578783. 
  • Cohn, J. N. (29 June 2004). “Introduction to Surrogate Markers”. Circulation 109 (25 suppl 1): IV–20–IV-21. doi:10.1161/01.CIR.0000133441.05780.1d. PMID 15226247. 
  • Core Outcomes in Women's Health (CROWN) Initiative (2014). “The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health”. Journal of Gynecologic Oncology 25 (3): 166–7. doi:10.3802/jgo.2014.25.3.166. PMC 4102731. PMID 25045427. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102731/. 
  • Penninckx, B; Van de Voorde, W M; Casado, A; Reed, N; Moulin, C; Karrasch, M (26 June 2012). “A systemic review of Toxic Death in clinical oncology trials: an Achilles' heel in safety reporting revisited”. British Journal of Cancer 107 (1): 1–6. doi:10.1038/bjc.2012.252. PMC 3389431. PMID 22677904. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389431/. 

ncbi.nlm.nih.gov

pmda.go.jp

uu.nl

vet.uu.nl

web.archive.org